{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:49:57Z","timestamp":1791989397140,"version":"4.4.0"},"reference-count":323,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004001","name":"Guizhou Province Science and Technology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020732","name":"Innovative Research Team of High-level Local Universities in Shanghai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.pharmthera.2026.109085","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:35:16Z","timestamp":1784763316000},"page":"109085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Metabolic reprogramming in pulmonary arterial hypertension"],"prefix":"10.1016","volume":"286","author":[{"given":"Jun-Zhuo","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Song","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Rui","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Fang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ou","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Han-Yue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Yi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Yang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.pharmthera.2026.109085_bb0005","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02308-2018","article-title":"CCR2\/CCR5-mediated macrophage-smooth muscle cell crosstalk in pulmonary hypertension","volume":"54","author":"Abid","year":"2019","journal-title":"The European Respiratory Journal"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109085_bb0010","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1161\/ATVBAHA.116.307634","article-title":"Neutrophil extracellular traps promote angiogenesis: Evidence from vascular pathology in pulmonary hypertension","volume":"36","author":"Aldabbous","year":"2016","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"8038","key":"10.1016\/j.pharmthera.2026.109085_bb0015","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-024-08085-6","article-title":"Chromatin remodelling drives immune cell-fibroblast communication in heart failure","volume":"635","author":"Alexanian","year":"2024","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109085_bb0020","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nrc.2016.71","article-title":"From Krebs to clinic: glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nature Reviews. Cancer"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1165\/rcmb.2022-0111OC","article-title":"Intracellular chloride channels regulate endothelial metabolic reprogramming in pulmonary arterial hypertension","volume":"68","author":"Alzaydi","year":"2023","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"25","key":"10.1016\/j.pharmthera.2026.109085_bb0030","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1161\/CIRCULATIONAHA.117.031655","article-title":"Pyruvate kinase and warburg metabolism in pulmonary arterial hypertension: Uncoupled glycolysis and the cancer-like phenotype of pulmonary arterial hypertension","volume":"136","author":"Archer","year":"2017","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0035","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12931-024-02775-5","article-title":"Unveiling the metabolic landscape of pulmonary hypertension: insights from metabolomics","volume":"25","author":"Ba","year":"2024","journal-title":"Respiratory Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb0040","doi-asserted-by":"crossref","first-page":"L1111","DOI":"10.1152\/ajplung.00431.2005","article-title":"Nitric oxide augments fetal pulmonary artery endothelial cell angiogenesis in vitro","volume":"290","author":"Balasubramaniam","year":"2006","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109085_bb0045","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1164\/rccm.201302-0302OC","article-title":"Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1\u03b1","volume":"189","author":"Ball","year":"2014","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109085_bb0050","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2026.109085_bb0055","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.3389\/fimmu.2019.02993","article-title":"New insights on the role of lipid metabolism in the metabolic reprogramming of macrophages","volume":"10","author":"Batista-Gonzalez","year":"2019","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2026.109085_bb0060","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9912434","article-title":"Resveratrol prevents right ventricle dysfunction, calcium mishandling, and energetic failure via SIRT3 stimulation in pulmonary arterial hypertension","volume":"2021","author":"Bernal-Ram\u00edrez","year":"2021","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109085_bb0065","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1172\/JCI86387","article-title":"Vascular stiffness mechanoactivates YAP\/TAZ-dependent glutaminolysis to drive pulmonary hypertension","volume":"126","author":"Bertero","year":"2016","journal-title":"The Journal of Clinical Investigation"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb0070","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/14728222.2019.1615438","article-title":"The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension","volume":"23","author":"Bertero","year":"2019","journal-title":"Expert Opinion on Therapeutic Targets"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109085_bb0075","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.cell.2013.06.037","article-title":"Role of PFKFB3-driven glycolysis in vessel sprouting","volume":"154","author":"Bock","year":"2013","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109085_bb0080","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1164\/rccm.201003-0335OC","article-title":"Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats","volume":"182","author":"Bogaard","year":"2010","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"22","key":"10.1016\/j.pharmthera.2026.109085_bb0085","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1161\/CIRCULATIONAHA.105.609008","article-title":"An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension","volume":"113","author":"Bonnet","year":"2006","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109085_bb0090","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1164\/rccm.202407-1345OC","article-title":"Lipid ratios for diagnosis and prognosis of pulmonary hypertension","volume":"211","author":"Bordag","year":"2025","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109085_bb0095","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/ATVBAHA.119.313715","article-title":"Lineage tracing reveals the dynamic contribution of pericytes to the blood vessel remodeling in pulmonary hypertension","volume":"40","author":"Bordenave","year":"2020","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109085_bb0100","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1161\/CIRCRESAHA.121.319971","article-title":"The latest in animal models of pulmonary hypertension and right ventricular failure","volume":"130","author":"Boucherat","year":"2022","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2026.109085_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1105565","article-title":"Acquired disorders of mitochondrial metabolism and dynamics in pulmonary arterial hypertension","volume":"11","author":"Breault","year":"2023","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"22","key":"10.1016\/j.pharmthera.2026.109085_bb0110","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018349","article-title":"Mechanistic phase II clinical trial of metformin in pulmonary arterial hypertension","volume":"9","author":"Brittain","year":"2020","journal-title":"Journal of the American Heart Association"},{"issue":"20","key":"10.1016\/j.pharmthera.2026.109085_bb0115","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1161\/CIRCULATIONAHA.115.019351","article-title":"Fatty acid metabolic defects and right ventricular lipotoxicity in human pulmonary arterial hypertension","volume":"133","author":"Brittain","year":"2016","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109085_bb0120","article-title":"Upregulation of GLUT-4 in right ventricle of rats with monocrotaline-induced pulmonary hypertension","volume":"14","author":"Broderick","year":"2008","journal-title":"Medical Science Monitor"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0125","doi-asserted-by":"crossref","DOI":"10.1177\/2045893217743966","article-title":"A prescribed walking regimen plus arginine supplementation improves function and quality of life for patients with pulmonary arterial hypertension: a pilot study","volume":"8","author":"Brown","year":"2018","journal-title":"Pulmonary circulation"},{"issue":"27","key":"10.1016\/j.pharmthera.2026.109085_bb0130","doi-asserted-by":"crossref","first-page":"13394","DOI":"10.1073\/pnas.1821401116","article-title":"PFKFB3-mediated endothelial glycolysis promotes pulmonary hypertension","volume":"116","author":"Cao","year":"2019","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2026.109085_bb0135","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jvssci.2021.04.001","article-title":"Targeting smooth muscle cell phenotypic switching in vascular disease","volume":"2","author":"Chakraborty","year":"2021","journal-title":"JVS-vascular science"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109085_bb0140","doi-asserted-by":"crossref","DOI":"10.65721\/rhj.2026.1.e10","article-title":"Real-world experience with sotatercept in pulmonary arterial hypertension: Hematologic effects and safety considerations","volume":"1","author":"Chan","year":"2026","journal-title":"Right Heart Journal"},{"issue":"140","key":"10.1016\/j.pharmthera.2026.109085_bb0145","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1183\/16000617.0036-2016","article-title":"Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives","volume":"25","author":"Chelladurai","year":"2016","journal-title":"European Respiratory Review: an official journal of the European Respiratory Society"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109085_bb0150","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1007\/s11010-025-05342-8","article-title":"Hypoxia-induced histone lactylation promotes pulmonary arterial smooth muscle cells proliferation in pulmonary hypertension","volume":"480","author":"Chen","year":"2025","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb0155","doi-asserted-by":"crossref","first-page":"L1151","DOI":"10.1152\/ajplung.00183.2009","article-title":"Hypoxia promotes human pulmonary artery smooth muscle cell proliferation through induction of arginase","volume":"297","author":"Chen","year":"2009","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"issue":"1-2","key":"10.1016\/j.pharmthera.2026.109085_bb0160","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11010-014-2194-0","article-title":"Serotonin drives the activation of pulmonary artery adventitial fibroblasts and TGF-\u03b21\/Smad3-mediated fibrotic responses through 5-HT(2A) receptors","volume":"397","author":"Chen","year":"2014","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109085_bb0165","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1111\/jcmm.14937","article-title":"Metabolomics reveals metabolite changes of patients with pulmonary arterial hypertension in China","volume":"24","author":"Chen","year":"2020","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0170","first-page":"208","article-title":"PI3K p85\u03b1\/HIF-1\u03b1 accelerates the development of pulmonary arterial hypertension by regulating fatty acid uptake and mitophagy","volume":"30","author":"Chen","year":"2024","journal-title":"Molecular Medicine (Cambridge, Mass.)"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109085_bb0175","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1164\/rccm.202301-0181OC","article-title":"Restoration of Foxp3+ regulatory T cells by HDAC-dependent epigenetic modulation plays a pivotal role in resolving pulmonary arterial hypertension pathology","volume":"208","author":"Chen","year":"2023","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109085_bb0180","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1084\/jem.20171767","article-title":"Inhibition of CRTH2-mediated Th2 activation attenuates pulmonary hypertension in mice","volume":"215","author":"Chen","year":"2018","journal-title":"The Journal of Experimental Medicine"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109085_bb0185","doi-asserted-by":"crossref","first-page":"251","DOI":"10.31083\/j.fbl2810251","article-title":"Serum metabolomic profile in hypoxia-induced pulmonary hypertension mice after C75 treatment","volume":"28","author":"Chen","year":"2023","journal-title":"Frontiers in Bioscience"},{"key":"10.1016\/j.pharmthera.2026.109085_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2025.106974","article-title":"Inhibition of glutaminase 1 reduces M1 macrophage polarization to protect against monocrotaline-induced pulmonary arterial hypertension","volume":"272","author":"Chen","year":"2025","journal-title":"Immunology Letters"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27062571","article-title":"Beyond the vasculature: The emerging role of systemic metabolism and immunometabolism in pulmonary arterial hypertension","volume":"27","author":"Chen","year":"2026","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109085_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9030260","article-title":"Hypoxia\/HIF modulates immune responses","volume":"9","author":"Chen","year":"2021","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109085_bb0205","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01325-2024","article-title":"Treatment algorithm for pulmonary arterial hypertension","volume":"64","author":"Chin","year":"2024","journal-title":"The European Respiratory Journal"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109085_bb0210","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ceb.2009.12.003","article-title":"Necroptosis as an alternative form of programmed cell death","volume":"22","author":"Christofferson","year":"2010","journal-title":"Current Opinion in Cell Biology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109085_bb0215","first-page":"646","article-title":"Swietenine alleviates vascular remodelling by enhancing mitophagy of pulmonary arterial smooth muscle cells in experimental pulmonary hypertension","volume":"39","author":"Chu","year":"2023","journal-title":"The Canadian Journal of Cardiology"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109085_bb0220","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1161\/CIRCRESAHA.123.323736","article-title":"GLI1+ cells contribute to vascular remodeling in pulmonary hypertension","volume":"134","author":"Chu","year":"2024","journal-title":"Circulation Research"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.109085_bb0225","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1093\/cvr\/cvaf146","article-title":"Mapping disease-specific vascular cell populations responsible for obliterative arterial remodelling during the development of pulmonary arterial hypertension","volume":"121","author":"Cober","year":"2025","journal-title":"Cardiovascular Research"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109085_bb0230","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1161\/CIRCRESAHA.116.305265","article-title":"Iron homeostasis and pulmonary hypertension: iron deficiency leads to pulmonary vascular remodeling in the rat","volume":"116","author":"Cotroneo","year":"2015","journal-title":"Circulation Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0235","doi-asserted-by":"crossref","first-page":"L54","DOI":"10.1152\/ajplung.00057.2024","article-title":"Aberrant long-chain fatty acid metabolism associated with evolving systemic sclerosis-associated pulmonary arterial hypertension","volume":"327","author":"Coursen","year":"2024","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"issue":"31","key":"10.1016\/j.pharmthera.2026.109085_bb0240","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1073\/pnas.1602978113","article-title":"HIF2\u03b1-arginase axis is essential for the development of pulmonary hypertension","volume":"113","author":"Cowburn","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109085_bb0245","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1172\/JCI120847","article-title":"Mitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountains","volume":"128","author":"Culley","year":"2018","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0250","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/CIRCRESAHA.122.321554","article-title":"BMPR2 mutation and metabolic reprogramming in pulmonary arterial hypertension","volume":"132","author":"Cuthbertson","year":"2023","journal-title":"Circulation Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0255","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1038\/s41467-019-10044-z","article-title":"A RASSF1A-HIF1\u03b1 loop drives Warburg effect in cancer and pulmonary hypertension","volume":"10","author":"Dabral","year":"2019","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0260","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s42003-024-06375-3","article-title":"C-type natriuretic peptide\/cGMP\/FoxO3 signaling attenuates hyperproliferation of pericytes from patients with pulmonary arterial hypertension","volume":"7","author":"Dabral","year":"2024","journal-title":"Communications Biology"},{"key":"10.1016\/j.pharmthera.2026.109085_bb0265","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1465-9921-12-60","article-title":"Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats","volume":"12","author":"Dahal","year":"2011","journal-title":"Respiratory Research"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109085_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26094265","article-title":"Vascular remodeling: the multicellular mechanisms of pulmonary hypertension","volume":"26","author":"Dai","year":"2025","journal-title":"International Journal of Molecular Sciences"},{"issue":"24","key":"10.1016\/j.pharmthera.2026.109085_bb0275","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1161\/CIRCULATIONAHA.116.021494","article-title":"Prolyl-4 hydroxylase 2 (PHD2) deficiency in endothelial cells and hematopoietic cells induces obliterative vascular remodeling and severe pulmonary arterial hypertension in mice and humans through hypoxia-inducible factor-2\u03b1","volume":"133","author":"Dai","year":"2016","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.pharmthera.2026.109085_bb0280","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12144722","article-title":"Pressure overload and right ventricular failure: From pathophysiology to treatment","volume":"12","author":"Dayer","year":"2023","journal-title":"Journal of Clinical Medicine"},{"issue":"49","key":"10.1016\/j.pharmthera.2026.109085_bb0285","doi-asserted-by":"crossref","first-page":"19345","DOI":"10.1073\/pnas.0709747104","article-title":"Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis","volume":"104","author":"DeBerardinis","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb0290","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s41440-022-00898-0","article-title":"Metabolomics-based mechanism exploration of pulmonary arterial hypertension pathogenesis: novel lessons from explanted human lungs","volume":"45","author":"Ding","year":"2022","journal-title":"Hypertension research: official journal of the Japanese Society of Hypertension"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109085_bb0295","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0300","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1086\/690236","article-title":"Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertension","volume":"7","author":"Egnatchik","year":"2017","journal-title":"Pulmonary circulation"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0305","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1096\/fj.05-4104fje","article-title":"Impact of HIF-1alpha and HIF-2alpha on proliferation and migration of human pulmonary artery fibroblasts in hypoxia","volume":"20","author":"Eul","year":"2006","journal-title":"FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109085_bb0310","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03957-2020","article-title":"Endothelial cells in the pathogenesis of pulmonary arterial hypertension","volume":"58","author":"Evans","year":"2021","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2026.109085_bb0315","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.542146","article-title":"Tribbles homolog 3-mediated vascular insulin resistance contributes to hypoxic pulmonary hypertension in intermittent hypoxia rat model","volume":"11","author":"Fan","year":"2020","journal-title":"Frontiers in Physiology"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109085_bb0320","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1164\/rccm.202308-1456ED","article-title":"Regulating the regulators: epigenetic modulation of regulatory T cells in pulmonary hypertension","volume":"208","author":"Farha","year":"2023","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"6487","key":"10.1016\/j.pharmthera.2026.109085_bb0325","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109085_bb0330","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3892\/ijmm.2013.1435","article-title":"EETs and CYP2J2 inhibit TNF-\u03b1-induced apoptosis in pulmonary artery endothelial cells and TGF-\u03b21-induced migration in pulmonary artery smooth muscle cells","volume":"32","author":"Feng","year":"2013","journal-title":"International Journal of Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2026.109085_bb0335","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/951497","article-title":"Pathogenic role of store-operated and receptor-operated Ca2+ channels in pulmonary arterial hypertension","volume":"2012","author":"Fernandez","year":"2012","journal-title":"Journal of Signal Transduction"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb0340","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41569-021-00558-9","article-title":"Sotatercept therapy for PAH","volume":"18","author":"Fern\u00e1ndez-Ruiz","year":"2021","journal-title":"Nature Reviews. Cardiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109085_bb0345","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2353\/ajpath.2010.090832","article-title":"Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells","volume":"176","author":"Fijalkowska","year":"2010","journal-title":"The American Journal of Pathology"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109085_bb0350","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202101264","article-title":"Loss of Amphiregulin drives inflammation and endothelial apoptosis in pulmonary hypertension","volume":"5","author":"Florentin","year":"2022","journal-title":"Life Science Alliance"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109085_bb0355","doi-asserted-by":"crossref","first-page":"226","DOI":"10.31083\/j.rcm2408226","article-title":"A review of therapeutic strategies against cardiac fibrosis: From classical pharmacology to novel molecular, epigenetic, and biotechnological approaches","volume":"24","author":"Floris","year":"2023","journal-title":"Reviews in Cardiovascular Medicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109085_bb0360","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1161\/01.CIR.96.9.2782","article-title":"Continuous infusion of prostacyclin normalizes plasma markers of endothelial cell injury and platelet aggregation in primary pulmonary hypertension","volume":"96","author":"Friedman","year":"1997","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0365","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1165\/rcmb.2017-0167OC","article-title":"Hypoxia upregulates estrogen receptor \u03b2 in pulmonary artery endothelial cells in a HIF-1\u03b1-dependent manner","volume":"59","author":"Frump","year":"2018","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109085_bb0370","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1086\/687766","article-title":"Sphingosine-1-phosphate is involved in the occlusive arteriopathy of pulmonary arterial hypertension","volume":"6","author":"Gairhe","year":"2016","journal-title":"Pulmonary circulation"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109085_bb0375","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jacc.2005.04.050","article-title":"Ambrisentan therapy for pulmonary arterial hypertension","volume":"46","author":"Gali\u00e9","year":"2005","journal-title":"Journal of the American College of Cardiology"},{"issue":"22","key":"10.1016\/j.pharmthera.2026.109085_bb0380","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","article-title":"Tadalafil therapy for pulmonary arterial hypertension","volume":"119","author":"Gali\u00e8","year":"2009","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.pharmthera.2026.109085_bb0385","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Gali\u00e8","year":"2005","journal-title":"The New England Journal of Medicine"},{"issue":"23","key":"10.1016\/j.pharmthera.2026.109085_bb0390","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1161\/CIRCULATIONAHA.107.742510","article-title":"Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2","volume":"117","author":"Gali\u00e8","year":"2008","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109085_bb0395","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109085_bb0400","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41569-024-01064-4","article-title":"Mechanisms and treatment of pulmonary arterial hypertension","volume":"22","author":"Ghofrani","year":"2025","journal-title":"Nature Reviews. Cardiology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109085_bb0405","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cmet.2012.12.016","article-title":"Deletion of iron regulatory protein 1 causes polycythemia and pulmonary hypertension in mice through translational derepression of HIF2\u03b1","volume":"17","author":"Ghosh","year":"2013","journal-title":"Cell Metabolism"},{"issue":"18","key":"10.1016\/j.pharmthera.2026.109085_bb0410","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1182\/blood.2020009138","article-title":"Therapeutic inhibition of HIF-2\u03b1 reverses polycythemia and pulmonary hypertension in murine models of human diseases","volume":"137","author":"Ghosh","year":"2021","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109085_bb0415","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0735-1097(01)01496-6","article-title":"Right ventricular ischemia in patients with primary pulmonary hypertension","volume":"38","author":"G\u00f3mez","year":"2001","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0420","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/CIRCHEARTFAILURE.111.966127","article-title":"Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension","volume":"6","author":"Gomez-Arroyo","year":"2013","journal-title":"Circulation Heart Failure"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0425","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/s41467-018-03672-4","article-title":"Identification of rare sequence variation underlying heritable pulmonary arterial hypertension","volume":"9","author":"Gr\u00e4f","year":"2018","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2026.109085_bb0430","article-title":"Tumor-produced ammonia is metabolized by regulatory T cells to further impede anti-tumor immunity","author":"Gu","year":"2025","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0435","doi-asserted-by":"crossref","first-page":"8658","DOI":"10.1038\/s41467-024-52666-y","article-title":"GLUT1 overexpression in CAR-T cells induces metabolic reprogramming and enhances potency","volume":"15","author":"Guerrero","year":"2024","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2026.109085_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcchd.2025.100571","article-title":"New therapies in pulmonary arterial hypertension: Recent insights","volume":"19","author":"Guglielmi","year":"2025","journal-title":"International Journal of Cardiology Congenital Heart Disease"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109085_bb0445","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01095-2024","article-title":"Pathology and pathobiology of pulmonary hypertension: current insights and future directions","volume":"64","author":"Guignabert","year":"2024","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2026.109085_bb0450","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1981568","article-title":"Current knowledge and recent advances of right ventricular molecular biology and metabolism from congenital heart disease to chronic pulmonary hypertension","volume":"2018","author":"Guimaron","year":"2018","journal-title":"BioMed Research International"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0455","doi-asserted-by":"crossref","DOI":"10.65721\/rhj.2026.1.e7","article-title":"Supportive role of sotatercept in maintenance after transition from parenteral prostacyclin to oral prostanoids in pulmonary arterial hypertension: A case report","volume":"1","author":"Ha","year":"2025","journal-title":"Right Heart Journal"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0460","doi-asserted-by":"crossref","first-page":"115","DOI":"10.7326\/L23-0387","article-title":"Recurrent gastrointestinal bleeding in a patient with pulmonary arterial hypertension treated with sotatercept","volume":"177","author":"Hakim","year":"2024","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109085_bb0465","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1067\/mai.2003.147","article-title":"Gross pathology and histopathology of asthma","volume":"111","author":"Hamid","year":"2003","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109085_bb0470","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1248\/bpb.b24-00831","article-title":"5-hydroxytryptamine limits pulmonary arterial hypertension progression by regulating Th17\/Treg balance","volume":"48","author":"Han","year":"2025","journal-title":"Biological & Pharmaceutical Bulletin"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109085_bb0475","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1165\/rcmb.2023-0244OC","article-title":"Ddx5 targeted epigenetic modification of pericytes in pulmonary hypertension after intrauterine growth restriction","volume":"70","author":"Hang","year":"2024","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0480","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12931-025-03182-0","article-title":"Altered maturation and activation state of circulating monocytes is associated with their enhanced recruitment in pulmonary arterial hypertension","volume":"26","author":"Harper","year":"2025","journal-title":"Respiratory Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109085_bb0485","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1161\/ATVBAHA.114.304865","article-title":"Endothelial uncoupling protein 2 regulates mitophagy and pulmonary hypertension during intermittent hypoxia","volume":"35","author":"Haslip","year":"2015","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109085_bb0490","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00522-2020","article-title":"Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension","volume":"56","author":"He","year":"2020","journal-title":"The European Respiratory Journal"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109085_bb0495","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/thx.33.4.468","article-title":"Resolution of pulmonary hypertension and other features induced by chronic hypoxia in rats during complete and intermittent normoxia","volume":"33","author":"Herget","year":"1978","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0500","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41598-019-57200-5","article-title":"Stable isotope metabolomics of pulmonary artery smooth muscle and endothelial cells in pulmonary hypertension and with TGF-beta treatment","volume":"10","author":"Hernandez-Saavedra","year":"2020","journal-title":"Scientific Reports"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109085_bb0505","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1007\/s10439-014-1096-3","article-title":"Structural and mechanical adaptations of right ventricle free wall myocardium to pressure overload","volume":"42","author":"Hill","year":"2014","journal-title":"Annals of Biomedical Engineering"},{"issue":"16","key":"10.1016\/j.pharmthera.2026.109085_bb0510","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJMoa2213558","article-title":"Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension","volume":"388","author":"Hoeper","year":"2023","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109085_bb0515","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S2213-2600(15)00543-3","article-title":"A global view of pulmonary hypertension","volume":"4","author":"Hoeper","year":"2016","journal-title":"The Lancet Respiratory Medicine"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109085_bb0520","doi-asserted-by":"crossref","first-page":"9783","DOI":"10.1007\/s11033-022-07474-2","article-title":"Immune cell metabolism and metabolic reprogramming","volume":"49","author":"Hu","year":"2022","journal-title":"Molecular Biology Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0525","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1165\/rcmb.2022-0114OC","article-title":"The effect of hypoxia-inducible factor inhibition on the phenotype of fibroblasts in human and bovine pulmonary hypertension","volume":"69","author":"Hu","year":"2023","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb0530","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.3892\/etm.2015.2376","article-title":"High levels of serum lactate dehydrogenase correlate with the severity and mortality of idiopathic pulmonary arterial hypertension","volume":"9","author":"Hu","year":"2015","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109085_bb0535","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1164\/rccm.202009-3419OC","article-title":"YTHDF1 regulates pulmonary hypertension through translational control of MAGED1","volume":"203","author":"Hu","year":"2021","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109085_bb0540","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1097\/CM9.0000000000003559","article-title":"Burden of pulmonary arterial hypertension in Asia from 1990 to 2021: Findings from Global Burden of Disease Study 2021","volume":"138","author":"Huang","year":"2025","journal-title":"Chinese Medical Journal"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109085_bb0545","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.5074","article-title":"Sildenafil protects against pulmonary hypertension induced by hypoxia in neonatal rats via activation of PPAR\u03b3-mediated downregulation of TRPC","volume":"49","author":"Huang","year":"2022","journal-title":"International Journal of Molecular Medicine"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109085_bb0550","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1161\/CIRCULATIONAHA.113.004555","article-title":"Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay","volume":"129","author":"Huertas","year":"2014","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb0555","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.chest.2016.01.004","article-title":"Regulatory T cell dysfunction in idiopathic, heritable and connective tissue-associated pulmonary arterial hypertension","volume":"149","author":"Huertas","year":"2016","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109085_bb0560","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/cvr\/cvz308","article-title":"Chronic inflammation within the vascular wall in pulmonary arterial hypertension: more than a spectator","volume":"116","author":"Huertas","year":"2020","journal-title":"Cardiovascular Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0565","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01887-2018","article-title":"Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives","volume":"53","author":"Humbert","year":"2019","journal-title":"The European Respiratory Journal"},{"issue":"38","key":"10.1016\/j.pharmthera.2026.109085_bb0570","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"European Heart Journal"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0575","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2023","journal-title":"The European Respiratory Journal"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.109085_bb0580","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1056\/NEJMoa2024277","article-title":"Sotatercept for the treatment of pulmonary arterial hypertension","volume":"384","author":"Humbert","year":"2021","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0585","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01347-2022","article-title":"Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension","volume":"61","author":"Humbert","year":"2023","journal-title":"The European Respiratory Journal"},{"issue":"20","key":"10.1016\/j.pharmthera.2026.109085_bb0590","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa2415160","article-title":"Sotatercept in patients with pulmonary arterial hypertension at high risk for death","volume":"392","author":"Humbert","year":"2025","journal-title":"The New England Journal of Medicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109085_bb0595","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S2213-2600(23)00264-3","article-title":"Treatment of pulmonary arterial hypertension: recent progress and a look to the future","volume":"11","author":"Humbert","year":"2023","journal-title":"The Lancet Respiratory Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb0600","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1161\/01.RES.0000141774.29937.e3","article-title":"Nuclear receptor signaling and cardiac energetics","volume":"95","author":"Huss","year":"2004","journal-title":"Circulation Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0605","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1161\/CIRCRESAHA.123.323546","article-title":"3D imaging reveals complex microvascular remodeling in the right ventricle in pulmonary hypertension","volume":"135","author":"Ichimura","year":"2024","journal-title":"Circulation Research"},{"issue":"19","key":"10.1016\/j.pharmthera.2026.109085_bb0610","article-title":"Macrophage plasticity and glucose metabolism: the role of immunometabolism in pulmonary arterial hypertension","volume":"138","author":"Jefferson","year":"2025","journal-title":"Clinical Science (London, England\u202f: 1979)"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109085_bb0615","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.immuni.2015.02.005","article-title":"Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization","volume":"42","author":"Jha","year":"2015","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109085_bb0620","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/molpharm.120.000019","article-title":"Transforming growth factor \u03b21 increases expression of contractile genes in human pulmonary arterial smooth muscle cells by potentiating sphingosine-1-phosphate signaling","volume":"100","author":"Ji","year":"2021","journal-title":"Molecular Pharmacology"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109085_bb0625","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/art.43235","article-title":"Activin A-activated ALK4 induces pathogenic Th17-involved endothelial-mesenchymal transition in systemic lupus erythematosus-associated pulmonary arterial hypertension","volume":"77","author":"Jing","year":"2025","journal-title":"Arthritis & Rheumatology"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109085_bb0630","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1164\/rccm.201101-0093OC","article-title":"Vardenafil in pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled study","volume":"183","author":"Jing","year":"2011","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb0635","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.jaci.2025.07.026","article-title":"IgE-activated human lung mast cells preferentially release prostaglandin D2, thromboxane A2, and cysteinyl-leukotrienes","volume":"156","author":"Johnsson","year":"2025","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109085_bb0640","doi-asserted-by":"crossref","first-page":"L773","DOI":"10.1152\/ajplung.00001.2020","article-title":"Hypoxic activation of glucose-6-phosphate dehydrogenase controls the expression of genes involved in the pathogenesis of pulmonary hypertension through the regulation of DNA methylation","volume":"318","author":"Joshi","year":"2020","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109085_bb0645","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/EBC20190041","article-title":"Metabolism","volume":"64","author":"Judge","year":"2020","journal-title":"Essays in Biochemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0650","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1086\/679720","article-title":"Arginine metabolic endotypes in pulmonary arterial hypertension","volume":"5","author":"Kao","year":"2015","journal-title":"Pulmonary circulation"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109085_bb0655","first-page":"597","article-title":"Adventitial fibroblasts induce a distinct proinflammatory\/profibrotic macrophage phenotype in pulmonary hypertension","volume":"193","author":"Kasmi","year":"2014","journal-title":"Journal of Immunology (Baltimore, Md.\u202f: 1950)"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109085_bb0660","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1253\/circj.CJ-20-0341","article-title":"Dapagliflozin influences ventricular hemodynamics and exercise-induced pulmonary hypertension in type 2 diabetes patients - a randomized controlled trial","volume":"84","author":"Kayano","year":"2020","journal-title":"Circulation Journal: Official Journal of the Japanese Circulation Society"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109085_bb0665","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/CIRCRESAHA.123.324138","article-title":"Ferroptosis-mediated inflammation promotes pulmonary hypertension","volume":"135","author":"Kazmirczak","year":"2024","journal-title":"Circulation Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109085_bb0670","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s44319-023-00054-w","article-title":"Pericytes contribute to pulmonary vascular remodeling via HIF2\u03b1 signaling","volume":"25","author":"Kim","year":"2024","journal-title":"EMBO Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0675","doi-asserted-by":"crossref","DOI":"10.4110\/in.2025.25.e13","article-title":"Regulatory T cell metabolism: A promising therapeutic target for cancer treatment?","volume":"25","author":"Kim","year":"2025","journal-title":"Immune Network"},{"key":"10.1016\/j.pharmthera.2026.109085_bb0680","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2015.45","article-title":"Epigenetic modulation as a therapeutic approach for pulmonary arterial hypertension","volume":"47","author":"Kim","year":"2015","journal-title":"Experimental & Molecular Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109085_bb0685","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/s44318-024-00349-1","article-title":"Specialized pericyte subtypes in the pulmonary capillaries","volume":"44","author":"Klouda","year":"2025","journal-title":"The EMBO Journal"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109085_bb0690","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14025","article-title":"Hypoxia-inducible factor-1 \u03b1 deletion in myeloid lineage attenuates hypoxia-induced pulmonary hypertension","volume":"7","author":"Kojima","year":"2019","journal-title":"Physiological Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0695","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000516780","article-title":"Metabolic regulation of macrophage activation","volume":"14","author":"Kolliniati","year":"2022","journal-title":"Journal of Innate Immunity"},{"issue":"16","key":"10.1016\/j.pharmthera.2026.109085_bb0700","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1093\/cvr\/cvad121","article-title":"Sotatercept as a next-generation therapy for pulmonary arterial hypertension: insights from the STELLAR trial","volume":"119","author":"Kope\u0107","year":"2023","journal-title":"Cardiovascular Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109085_bb0705","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1164\/rccm.201812-2290OC","article-title":"PFKFB3 in smooth muscle promotes vascular remodeling in pulmonary arterial hypertension","volume":"200","author":"Kovacs","year":"2019","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109085_bb0710","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1086\/683810","article-title":"Profiling the role of mammalian target of rapamycin in the vascular smooth muscle metabolome in pulmonary arterial hypertension","volume":"5","author":"Kudryashova","year":"2015","journal-title":"Pulmonary circulation"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109085_bb0715","doi-asserted-by":"crossref","first-page":"H1546","DOI":"10.1152\/ajpheart.00944.2011","article-title":"New mechanisms of pulmonary arterial hypertension: role of Ca2+ signaling","volume":"302","author":"Kuhr","year":"2012","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109085_bb0720","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.186000","article-title":"Metabolic fitness of NAC1-deficient Tregs in the tumor microenvironment fuels tumor growth","volume":"10","author":"Kumar","year":"2025","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109085_bb0725","first-page":"1081","article-title":"Ca2+ and ion channels in hypoxia-mediated pulmonary hypertension","volume":"8","author":"Lai","year":"2015","journal-title":"International Journal of Clinical and Experimental Pathology"},{"issue":"26","key":"10.1016\/j.pharmthera.2026.109085_bb0730","doi-asserted-by":"crossref","first-page":"13122","DOI":"10.1073\/pnas.1822010116","article-title":"Intracellular iron deficiency in pulmonary arterial smooth muscle cells induces pulmonary arterial hypertension in mice","volume":"116","author":"Lakhal-Littleton","year":"2019","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7565","key":"10.1016\/j.pharmthera.2026.109085_bb0735","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nature14893","article-title":"The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy","volume":"524","author":"Lazarou","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0740","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.chest.2021.08.040","article-title":"Phenotypic diversity of vascular smooth muscle cells in pulmonary arterial hypertension: Implications for therapy","volume":"161","author":"Lechartier","year":"2022","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109085_bb0745","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.4070\/kcj.2018.0061","article-title":"Protective effect of right ventricular mitochondrial damage by cyclosporine A in monocrotaline-induced pulmonary hypertension","volume":"48","author":"Lee","year":"2018","journal-title":"Korean Circulation Journal"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109085_bb0750","doi-asserted-by":"crossref","first-page":"L355","DOI":"10.1152\/ajplung.00039.2022","article-title":"Contribution of fatty acid oxidation to the pathogenesis of pulmonary hypertension","volume":"323","author":"Lee","year":"2022","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"issue":"438","key":"10.1016\/j.pharmthera.2026.109085_bb0755","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao0303","article-title":"PPAR\u03b3 agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation","volume":"10","author":"Legchenko","year":"2018","journal-title":"Science Translational Medicine"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109085_bb0760","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1164\/rccm.202305-0909OC","article-title":"Hypusine signaling promotes pulmonary vascular remodeling in pulmonary arterial hypertension","volume":"209","author":"Lemay","year":"2024","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0765","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1038\/s41467-022-30633-9","article-title":"Identification, discrimination and heterogeneity of fibroblasts","volume":"13","author":"Lendahl","year":"2022","journal-title":"Nature Communications"},{"issue":"21","key":"10.1016\/j.pharmthera.2026.109085_bb0770","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1161\/CIRCULATIONAHA.120.048845","article-title":"ALDH1A3 coordinates metabolism with gene regulation in pulmonary arterial hypertension","volume":"143","author":"Li","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0775","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1159\/000495243","article-title":"SphK1\/S1P mediates PDGF-induced pulmonary arterial smooth muscle cell proliferation via miR-21\/BMPRII\/Id1 signaling pathway","volume":"51","author":"Li","year":"2018","journal-title":"Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109085_bb0780","first-page":"e114","article-title":"ca-circSCN8A promotes HPASMCs ferroptosis via LLPS initiated R-loop","volume":"82","author":"Li","year":"2025","journal-title":"Hypertension (Dallas, Tex.: 1979)"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109085_bb0785","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1165\/rcmb.2022-0360OC","article-title":"SIRT3 is a critical regulator of mitochondrial function of fibroblasts in pulmonary hypertension","volume":"69","author":"Li","year":"2023","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2026.109085_bb0790","article-title":"Microenvironmental regulation of macrophage transcriptomic and metabolomic profiles in pulmonary hypertension","volume":"12","author":"Li","year":"2021","journal-title":"Frontiers in Immunology"},{"issue":"15","key":"10.1016\/j.pharmthera.2026.109085_bb0795","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1161\/CIRCULATIONAHA.116.023171","article-title":"Metabolic reprogramming regulates the proliferative and inflammatory phenotype of adventitial fibroblasts in pulmonary hypertension through the transcriptional corepressor C-terminal binding protein-1","volume":"134","author":"Li","year":"2016","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109085_bb0800","doi-asserted-by":"crossref","DOI":"10.1042\/CS20255922","article-title":"LONP1 facilitates pulmonary artery smooth muscle cell glycolytic reprogramming by degrading MPC1 in pulmonary hypertension","volume":"139","author":"Li","year":"2025","journal-title":"Clinical Science (London, England : 1979)"},{"key":"10.1016\/j.pharmthera.2026.109085_bb0805","article-title":"Combination of dichloroacetate and atorvastatin regulates excessive proliferation and oxidative stress in pulmonary arterial hypertension development via p38 signaling","volume":"2020","author":"Li","year":"2020","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0810","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/CIRCRESAHA.124.323698","article-title":"SMYD2-methylated PPAR\u03b3 facilitates hypoxia-induced pulmonary hypertension by activating mitophagy","volume":"135","author":"Li","year":"2024","journal-title":"Circulation Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0815","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41420-022-01200-4","article-title":"Arginase: Shedding light on the mechanisms and opportunities in cardiovascular diseases","volume":"8","author":"Li","year":"2022","journal-title":"Cell Death Discovery"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109085_bb0820","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10020341","article-title":"Mitochondrial metabolism, redox, and calcium homeostasis in pulmonary arterial hypertension","volume":"10","author":"Liang","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.pharmthera.2026.109085_bb0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2022.104471","article-title":"PRDX6-mediated pulmonary artery endothelial cell ferroptosis contributes to monocrotaline-induced pulmonary hypertension","volume":"146","author":"Liao","year":"2023","journal-title":"Microvascular Research"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109085_bb0830","doi-asserted-by":"crossref","DOI":"10.3390\/genes13122301","article-title":"Fatty acid metabolism in endothelial cell","volume":"13","author":"Liu","year":"2022","journal-title":"Genes"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb0835","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02643-2021","article-title":"Endothelial PHD2 deficiency induces nitrative stress via suppression of caveolin-1 in pulmonary hypertension","volume":"60","author":"Liu","year":"2022","journal-title":"The European Respiratory Journal"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109085_bb0840","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1161\/ATVBAHA.124.321173","article-title":"Single-cell and spatial transcriptomics identified fatty acid-binding proteins controlling endothelial glycolytic and arterial programming in pulmonary hypertension","volume":"45","author":"Liu","year":"2025","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109085_bb0845","doi-asserted-by":"crossref","DOI":"10.35534\/jrbtm.2024.10007","article-title":"A novel animal model for pulmonary hypertension: Lung endothelial-specific deletion of egln1 in mice","volume":"1","author":"Liu","year":"2024","journal-title":"Journal of Respiratory Biology and Translational Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109085_bb0850","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/CIRCULATIONAHA.123.067981","article-title":"General capillary endothelial cells undergo reprogramming into arterial endothelial cells in pulmonary hypertension through HIF-2\u03b1\/Notch4 pathway","volume":"150","author":"Liu","year":"2024","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0855","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41392-025-02141-x","article-title":"Energy metabolism in health and diseases","volume":"10","author":"Liu","year":"2025","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb0860","first-page":"2400","article-title":"IL-17 promotes neutrophil-mediated immunity by activating microvascular pericytes and not endothelium","volume":"197","author":"Liu","year":"2016","journal-title":"Journal of Immunology (Baltimore, Md.\u202f: 1950)"},{"key":"10.1016\/j.pharmthera.2026.109085_bb0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111594","article-title":"NSD2 mediated H3K36me2 promotes pulmonary arterial hypertension by recruiting FOLR1 and metabolism reprogramming","volume":"127","author":"Liu","year":"2025","journal-title":"Cellular Signalling"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0870","doi-asserted-by":"crossref","first-page":"L17","DOI":"10.1152\/ajplung.00063.2009","article-title":"Knockdown of stromal interaction molecule 1 attenuates store-operated Ca2+ entry and Ca2+ responses to acute hypoxia in pulmonary arterial smooth muscle","volume":"297","author":"Lu","year":"2009","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109085_bb0875","doi-asserted-by":"crossref","first-page":"736","DOI":"10.7150\/thno.79876","article-title":"Cellular mitophagy: Mechanism, roles in diseases and small molecule pharmacological regulation","volume":"13","author":"Lu","year":"2023","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109085_bb0880","first-page":"5655","article-title":"Qiliqiangxin prevents right ventricular remodeling by inhibiting apoptosis and improving metabolism reprogramming with pulmonary arterial hypertension","volume":"12","author":"Lu","year":"2020","journal-title":"American Journal of Translational Research"},{"issue":"17","key":"10.1016\/j.pharmthera.2026.109085_bb0885","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/CIRCULATIONAHA.123.067579","article-title":"Inactivation of Malic Enzyme 1 in Endothelial Cells Alleviates Pulmonary Hypertension","volume":"149","author":"Luo","year":"2024","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109085_bb0890","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103559","article-title":"Pulmonary artery smooth muscle cell phenotypic switching: A key event in the early stage of pulmonary artery hypertension","volume":"28","author":"Ma","year":"2023","journal-title":"Drug Discovery Today"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb0895","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1164\/rccm.201108-1562OC","article-title":"Lung 18F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension","volume":"185","author":"Marsboom","year":"2012","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0900","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01214-2017","article-title":"The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension","volume":"51","author":"Marsh","year":"2018","journal-title":"The European Respiratory Journal"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109085_bb0905","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1161\/CIRCRESAHA.122.321041","article-title":"Orai1 inhibitors as potential treatments for pulmonary arterial hypertension","volume":"131","author":"Masson","year":"2022","journal-title":"Circulation Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109085_bb0910","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1039\/B511249B","article-title":"Hypoxia-inducible factor prolyl hydroxylase 2 has a high affinity for ferrous iron and 2-oxoglutarate","volume":"1","author":"McNeill","year":"2005","journal-title":"Molecular BioSystems"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0915","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12872-024-04000-z","article-title":"\u03b2-catenin mediates monocrotaline-induced pulmonary hypertension via glycolysis in rats","volume":"24","author":"Meng","year":"2024","journal-title":"BMC Cardiovascular Disorders"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb0920","first-page":"3299","article-title":"Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets","volume":"186","author":"Michalek","year":"2011","journal-title":"Journal of Immunology (Baltimore, Md.\u202f: 1950)"},{"issue":"413","key":"10.1016\/j.pharmthera.2026.109085_bb0925","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao4583","article-title":"Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients","volume":"9","author":"Michelakis","year":"2017","journal-title":"Science Translational Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0930","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.celrep.2019.03.029","article-title":"HIF-1\u03b1 is a metabolic switch between glycolytic-driven migration and oxidative phosphorylation-driven immunosuppression of tregs in glioblastoma","volume":"27","author":"Miska","year":"2019","journal-title":"Cell Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0935","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-023-00486-7","article-title":"Pulmonary hypertension","volume":"10","author":"Mocumbi","year":"2024","journal-title":"Nature Reviews. Disease Primers"},{"key":"10.1016\/j.pharmthera.2026.109085_bb0940","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3389\/fimmu.2014.00569","article-title":"Mast cell mediators: their differential release and the secretory pathways involved","volume":"5","author":"Moon","year":"2014","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2026.109085_bb0945","article-title":"Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416\/hypoxia rat model","volume":"14","author":"Morales-Cano","year":"2023","journal-title":"Frontiers in Pharmacology"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109085_bb0950","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076619","article-title":"Pathophysiological involvement of mast cells and the lipid mediators in pulmonary vascular remodeling","volume":"24","author":"Moriyama","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0955","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1038\/s41467-022-30621-z","article-title":"Omega-3 fatty acid epoxides produced by PAF-AH2 in mast cells regulate pulmonary vascular remodeling","volume":"13","author":"Moriyama","year":"2022","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2026.109085_bb0960","article-title":"Pericytes and lung vascular remodeling","author":"Moss","year":"2025","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109085_bb0965","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1161\/01.ATV.0000186184.33537.48","article-title":"Statin protects endothelial nitric oxide synthase activity in hypoxia-induced pulmonary hypertension","volume":"25","author":"Murata","year":"2005","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb0970","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02334-2021","article-title":"The physiological basis of pulmonary arterial hypertension","volume":"59","author":"Naeije","year":"2022","journal-title":"The European Respiratory Journal"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb0975","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14061303","article-title":"Metabolic reprogramming in cancer cells: Emerging molecular mechanisms and novel therapeutic approaches","volume":"14","author":"Navarro","year":"2022","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109085_bb0980","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1161\/CIRCRESAHA.122.321725","article-title":"Targeting Wnt-\u00df-Catenin-FOSL Signaling Ameliorates Right Ventricular Remodeling","volume":"132","author":"Nayakanti","year":"2023","journal-title":"Circulation Research"},{"issue":"Suppl","key":"10.1016\/j.pharmthera.2026.109085_bb0985","first-page":"1","article-title":"Mitochondrial dysfunction dictates energy metabolism reprogramming in pulmonary arterial hypertension","volume":"36","author":"Niihori","year":"2022","journal-title":"FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb0990","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/s42003-025-08661-0","article-title":"C-type natriuretic peptide attenuates enhanced glycolysis and de novo pyrimidine synthesis in pericytes of patients with pulmonary arterial hypertension","volume":"8","author":"Noh","year":"2025","journal-title":"Communications Biology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109085_bb0995","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.218","article-title":"Metabolic reprogramming in cancer: Mechanisms and therapeutics","volume":"4","author":"Nong","year":"2023","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb1000","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97470-6","article-title":"Right ventricular myocardial oxygen tension is reduced in monocrotaline-induced pulmonary hypertension in the rat and restored by myo-inositol trispyrophosphate","volume":"11","author":"Okni\u0144ska","year":"2021","journal-title":"Scientific Reports"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109085_bb1005","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa020204","article-title":"Inhaled iloprost for severe pulmonary hypertension","volume":"347","author":"Olschewski","year":"2002","journal-title":"The New England Journal of Medicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109085_bb1010","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1161\/CIRCRESAHA.118.314187","article-title":"TEAD1 (TEA domain transcription factor 1) promotes smooth muscle cell proliferation through upregulating SLC1A5 (solute carrier family 1 member 5)-mediated glutamine uptake","volume":"124","author":"Osman","year":"2019","journal-title":"Circulation Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb1015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cmet.2014.12.005","article-title":"Pyruvate kinase M2 regulates Hif-1\u03b1 activity and IL-1\u03b2 induction and is a critical determinant of the warburg effect in LPS-activated macrophages","volume":"21","author":"Palsson-McDermott","year":"2015","journal-title":"Cell Metabolism"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109085_bb1020","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1111\/febs.15853","article-title":"Metabolic rewiring: a new master of Th17 cell plasticity and heterogeneity","volume":"289","author":"Papadopoulou","year":"2022","journal-title":"The FEBS Journal"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1025","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1038\/ncomms7692","article-title":"PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation","volume":"6","author":"Patsoukis","year":"2015","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb1030","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/CIRCRESAHA.115.301130","article-title":"The metabolic theory of pulmonary arterial hypertension","volume":"115","author":"Paulin","year":"2014","journal-title":"Circulation Research"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109085_bb1035","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1161\/CIRCRESAHA.117.311082","article-title":"Autophagy and mitophagy in cardiovascular disease","volume":"120","author":"Pedro","year":"2017","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-61779-034-8_1","article-title":"Current status of the polyamine research field","volume":"720","author":"Pegg","year":"2011","journal-title":"Methods in Molecular Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109085_bb1045","doi-asserted-by":"crossref","first-page":"L252","DOI":"10.1152\/ajplung.00199.2023","article-title":"Fatty acid metabolism promotes TRPV4 activity in lung microvascular endothelial cells in pulmonary arterial hypertension","volume":"326","author":"Philip","year":"2024","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109085_bb1050","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1161\/CIRCRESAHA.122.321923","article-title":"Metabolomic signatures associated with pulmonary arterial hypertension outcomes","volume":"132","author":"Pi","year":"2023","journal-title":"Circulation Research"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109085_bb1055","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s00109-013-1064-7","article-title":"Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension","volume":"91","author":"Piao","year":"2013","journal-title":"Journal of Molecular Medicine (Berlin, Germany)"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109085_bb1060","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00109-010-0679-1","article-title":"Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure","volume":"88","author":"Piao","year":"2010","journal-title":"Journal of Molecular Medicine (Berlin, Germany)"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109085_bb1065","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00109-012-0982-0","article-title":"FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate","volume":"91","author":"Piao","year":"2013","journal-title":"Journal of Molecular Medicine (Berlin, Germany)"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb1070","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1165\/rcmb.2015-0142OC","article-title":"Constitutive reprogramming of fibroblast mitochondrial metabolism in pulmonary hypertension","volume":"55","author":"Plecit\u00e1-Hlavat\u00e1","year":"2016","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1075","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102797","article-title":"Metabolic reprogramming, oxidative stress, and pulmonary hypertension","volume":"64","author":"Pokharel","year":"2023","journal-title":"Redox Biology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb1080","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.184141","article-title":"An intracellular complement system drives metabolic and proinflammatory reprogramming of vascular fibroblasts in pulmonary hypertension","volume":"10","author":"Prasad","year":"2025","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb1085","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01435-2024","article-title":"A long-term follow-up study of sotatercept for treatment of pulmonary arterial hypertension: interim results of SOTERIA","volume":"66","author":"Preston","year":"2025","journal-title":"The European Respiratory Journal"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109085_bb1090","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jacbts.2021.09.004","article-title":"With no lysine kinase 1 promotes metabolic derangements and RV dysfunction in pulmonary arterial hypertension","volume":"6","author":"Prisco","year":"2021","journal-title":"JACC. Basic to Translational Science"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109085_bb1095","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1213917","article-title":"Macitentan and morbidity and mortality in pulmonary arterial hypertension","volume":"369","author":"Pulido","year":"2013","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1100","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001422","article-title":"Advanced molecular, metabolic, and imaging approaches to characterizing right ventricular failure: A scientific statement from the American Heart Association","author":"Pullamsetti","year":"2026","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb1105","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1161\/CIRCRESAHA.125.326173","article-title":"MHCIIhiLYVE1loCCR2hi interstitial macrophages promote medial fibrosis in pulmonary arterioles and contribute to pulmonary hypertension","volume":"137","author":"Qiu","year":"2025","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1110","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.639541","article-title":"Donepezil ameliorates pulmonary arterial hypertension by inhibiting M2-macrophage activation","volume":"8","author":"Qiu","year":"2021","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109085_bb1115","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.scib.2025.04.014","article-title":"Pulmonary arterial hypertension: a long-standing and nonnegligible burden over three decades","volume":"70","author":"Qiu","year":"2025","journal-title":"Science Bulletin"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb1120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCRESAHA.113.301141","article-title":"Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension","volume":"115","author":"Rabinovitch","year":"2014","journal-title":"Circulation Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb1125","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.cmet.2024.04.010","article-title":"Dietary intake and glutamine-serine metabolism control pathologic vascular stiffness","volume":"36","author":"Rachedi","year":"2024","journal-title":"Cell Metabolism"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109085_bb1130","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/CIRCRESAHA.123.322740","article-title":"Altered smooth muscle cell histone acetylome by the SPHK2\/S1P axis promotes pulmonary hypertension","volume":"133","author":"Ranasinghe","year":"2023","journal-title":"Circulation Research"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109085_bb1135","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1164\/rccm.202501-0034OC","article-title":"Metabolomic evidence of biological overlap with heart failure with preserved ejection fraction in a subset of pulmonary arterial hypertension","volume":"211","author":"Reddy","year":"2025","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb1140","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1165\/rcmb.2024-0349OC","article-title":"PINK1\/parkin deficiency enhances vascular remodeling and aggravates hypoxia-induced pulmonary hypertension","volume":"73","author":"Rehman","year":"2025","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109085_bb1145","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02350-2020","article-title":"The cancer hypothesis of pulmonary arterial hypertension: are polyamines the new Warburg?","volume":"56","author":"Rhodes","year":"2020","journal-title":"The European Respiratory Journal"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109085_bb1150","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1161\/CIRCULATIONAHA.116.024602","article-title":"Plasma metabolomics implicates modified transfer RNAs and altered bioenergetics in the outcomes of pulmonary arterial hypertension","volume":"135","author":"Rhodes","year":"2017","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.pharmthera.2026.109085_bb1155","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1161\/CIRCULATIONAHA.113.007469","article-title":"Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle-like cells in pulmonary hypertension","volume":"129","author":"Ricard","year":"2014","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109085_bb1160","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"The New England Journal of Medicine"},{"issue":"14","key":"10.1016\/j.pharmthera.2026.109085_bb1165","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.2022.4402","article-title":"Diagnosis and treatment of pulmonary arterial hypertension: A review","volume":"327","author":"Ruopp","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb1170","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCRESAHA.113.301129","article-title":"The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure","volume":"115","author":"Ryan","year":"2014","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1175","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.yjmcc.2018.04.003","article-title":"Ca2+ handling remodeling and STIM1L\/Orai1\/TRPC1\/TRPC4 upregulation in monocrotaline-induced right ventricular hypertrophy","volume":"118","author":"Sabourin","year":"2018","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"44","key":"10.1016\/j.pharmthera.2026.109085_bb1180","doi-asserted-by":"crossref","first-page":"30058","DOI":"10.1021\/acsami.6b12875","article-title":"Bioinorganic nanohybrid catalyst for multistep synthesis of acetaminophen, an analgesic","volume":"8","author":"San","year":"2016","journal-title":"ACS Applied Materials & Interfaces"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109085_bb1185","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1164\/rccm.202203-0450OC","article-title":"SOX17 deficiency mediates pulmonary hypertension: At the crossroads of sex, metabolism, and genetics","volume":"207","author":"Sangam","year":"2023","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109085_bb1190","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01949-2023","article-title":"B-cells in pulmonary arterial hypertension: Friend, foe or bystander?","volume":"63","author":"Sanges","year":"2024","journal-title":"The European Respiratory Journal"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109085_bb1195","doi-asserted-by":"crossref","DOI":"10.3390\/biom12040484","article-title":"Role of ion channel remodeling in endothelial dysfunction induced by pulmonary arterial hypertension","volume":"12","author":"Santos-Gomes","year":"2022","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109085_bb1200","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrcardio.2011.87","article-title":"Mechanisms of disease: pulmonary arterial hypertension","volume":"8","author":"Schermuly","year":"2011","journal-title":"Nature Reviews. Cardiology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109085_bb1205","first-page":"614","article-title":"Characterization of inflammatory mediator release from purified human lung mast cells","volume":"133","author":"Schleimer","year":"1986","journal-title":"The American Review of Respiratory Disease"},{"issue":"7546","key":"10.1016\/j.pharmthera.2026.109085_bb1210","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nature14362","article-title":"Fatty acid carbon is essential for dNTP synthesis in endothelial cells","volume":"520","author":"Schoors","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1215","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111527","article-title":"Death-associated protein kinase 1 prevents hypoxia-induced metabolic shift and pulmonary arterial smooth muscle cell proliferation in PAH","volume":"127","author":"Seidel","year":"2025","journal-title":"Cellular Signalling"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1220","doi-asserted-by":"crossref","first-page":"11635","DOI":"10.1038\/ncomms11635","article-title":"HIF-1\u03b1-PDK1 axis-induced active glycolysis plays an essential role in macrophage migratory capacity","volume":"7","author":"Semba","year":"2016","journal-title":"Nature Communications"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109085_bb1225","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1161\/CIRCULATIONAHA.120.048191","article-title":"MDM2-mediated ubiquitination of angiotensin-converting enzyme 2 contributes to the development of pulmonary arterial hypertension","volume":"142","author":"Shen","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1230","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154778","article-title":"Glutamine metabolism: from proliferating cells to cardiomyocytes","volume":"121","author":"Shen","year":"2021","journal-title":"Metabolism, Clinical and Experimental"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1235","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.yjmcc.2024.10.004","article-title":"Panorama of artery endothelial cell dysfunction in pulmonary arterial hypertension","volume":"197","author":"Shen","year":"2024","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109085_bb1240","doi-asserted-by":"crossref","first-page":"H613","DOI":"10.1152\/ajpheart.00220.2020","article-title":"Metabolism of vascular smooth muscle cells in vascular diseases","volume":"319","author":"Shi","year":"2020","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109085_bb1245","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1161\/HYPERTENSIONAHA.122.19857","article-title":"Targeting endothelial ENO1 (alpha-enolase) -PI3K-Akt-mTOR axis alleviates hypoxic pulmonary hypertension","volume":"80","author":"Shi","year":"2023","journal-title":"Hypertension (Dallas, Tex.: 1979)"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb1250","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial","volume":"165","author":"Simonneau","year":"2002","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1255","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ejphar.2017.09.042","article-title":"Fatty acid synthase modulates proliferation, metabolic functions and angiogenesis in hypoxic pulmonary artery endothelial cells","volume":"815","author":"Singh","year":"2017","journal-title":"European Journal of Pharmacology"},{"issue":"26","key":"10.1016\/j.pharmthera.2026.109085_bb1260","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMoa1503184","article-title":"Selexipag for the treatment of pulmonary arterial hypertension","volume":"373","author":"Sitbon","year":"2015","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1265","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fmolb.2018.00120","article-title":"Metabolic alterations in cardiopulmonary vascular dysfunction","volume":"5","author":"Smolders","year":"2018","journal-title":"Frontiers in Molecular Biosciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb1270","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1038\/s41598-022-06238-z","article-title":"Metabolic profile in endothelial cells of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension","volume":"12","author":"Smolders","year":"2022","journal-title":"Scientific Reports"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109085_bb1275","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023021","article-title":"Platelet-derived growth factor receptor type \u03b1 activation drives pulmonary vascular remodeling via progenitor cell proliferation and induces pulmonary hypertension","volume":"11","author":"Solinc","year":"2022","journal-title":"Journal of the American Heart Association"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109085_bb1280","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/HYPERTENSIONAHA.117.10503","article-title":"STIM2 (stromal interaction molecule 2)-mediated increase in resting cytosolic free Ca2+ concentration stimulates PASMC proliferation in pulmonary arterial hypertension","volume":"71","author":"Song","year":"2018","journal-title":"Hypertension (Dallas, Tex.: 1979)"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109085_bb1285","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01107-2023","article-title":"Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial","volume":"62","author":"Souza","year":"2023","journal-title":"The European Respiratory Journal"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109085_bb1290","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1152\/japplphysiol.00283.2015","article-title":"Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension","volume":"119","author":"Stenmark","year":"2015","journal-title":"Journal of Applied Physiology (Bethesda, MD: 1985)"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb1295","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1165\/rcmb.2013-0187OC","article-title":"Endothelin-1 induces a glycolytic switch in pulmonary arterial endothelial cells via the mitochondrial translocation of endothelial nitric oxide synthase","volume":"50","author":"Sun","year":"2014","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109085_bb1300","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1086\/681227","article-title":"Fatty acid metabolism in pulmonary arterial hypertension: role in right ventricular dysfunction and hypertrophy","volume":"5","author":"Talati","year":"2015","journal-title":"Pulmonary circulation"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109085_bb1305","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1161\/CIRCRESAHA.117.312058","article-title":"Dominant role for regulatory T cells in protecting females against pulmonary hypertension","volume":"122","author":"Tamosiuniene","year":"2018","journal-title":"Circulation Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb1310","doi-asserted-by":"crossref","first-page":"10154","DOI":"10.1038\/s41598-022-14307-6","article-title":"Integrated bioinformatics analysis reveals marker genes and immune infiltration for pulmonary arterial hypertension","volume":"12","author":"Tang","year":"2022","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1315","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3389\/fphys.2018.00828","article-title":"Increased Drp1-mediated mitochondrial fission promotes proliferation and collagen production by right ventricular fibroblasts in experimental pulmonary arterial hypertension","volume":"9","author":"Tian","year":"2018","journal-title":"Frontiers in Physiology"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109085_bb1320","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/CIRCRESAHA.120.316443","article-title":"Epigenetic metabolic reprogramming of right ventricular fibroblasts in pulmonary arterial hypertension: A pyruvate dehydrogenase kinase-dependent shift in mitochondrial metabolism promotes right ventricular fibrosis","volume":"126","author":"Tian","year":"2020","journal-title":"Circulation Research"},{"issue":"17","key":"10.1016\/j.pharmthera.2026.109085_bb1325","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1161\/CIRCULATIONAHA.119.040629","article-title":"Phenotypically silent bone morphogenetic protein receptor 2 mutations predispose rats to inflammation-induced pulmonary arterial hypertension by enhancing the risk for neointimal transformation","volume":"140","author":"Tian","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109085_bb1330","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/ncb1556","article-title":"Uncoupling proteins 2 and 3 are fundamental for mitochondrial Ca2+ uniport","volume":"9","author":"Trenker","year":"2007","journal-title":"Nature Cell Biology"},{"issue":"17","key":"10.1016\/j.pharmthera.2026.109085_bb1335","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1161\/CIRCULATIONAHA.106.632208","article-title":"Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure","volume":"114","author":"Voelkel","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1340","doi-asserted-by":"crossref","DOI":"10.1038\/cddiscovery.2017.74","article-title":"Orai1, 2, 3 and STIM1 promote store-operated calcium entry in pulmonary arterial smooth muscle cells","volume":"3","author":"Wang","year":"2017","journal-title":"Cell Death Discovery"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109085_bb1345","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1161\/HYPERTENSIONAHA.123.22393","article-title":"PD-1\/PD-L1 provides protective role in hypoxia-induced pulmonary vascular remodeling","volume":"81","author":"Wang","year":"2024","journal-title":"Hypertension (Dallas, Tex.: 1979)"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109085_bb1350","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/bph.15339","article-title":"Mice with a specific deficiency of Pfkfb3 in myeloid cells are protected from hypoxia-induced pulmonary hypertension","volume":"178","author":"Wang","year":"2021","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb1355","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s12967-025-06384-8","article-title":"Mfn2 regulates calcium homeostasis and suppresses PASMCs proliferation via interaction with IP3R3 to mitigate pulmonary arterial hypertension","volume":"23","author":"Wang","year":"2025","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1360","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106238","article-title":"Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective","volume":"180","author":"Wang","year":"2022","journal-title":"Pharmacological Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109085_bb1365","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00109-014-1216-4","article-title":"Peroxisome proliferator-activated receptor \u03b3 inhibits pulmonary hypertension targeting store-operated calcium entry","volume":"93","author":"Wang","year":"2015","journal-title":"Journal of Molecular Medicine (Berlin, Germany)"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb1370","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1186\/s12967-023-04268-3","article-title":"Elevated CHCHD4 orchestrates mitochondrial oxidative phosphorylation to disturb hypoxic pulmonary hypertension","volume":"21","author":"Wang","year":"2023","journal-title":"Journal of Translational Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109085_bb1375","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/s41440-024-01607-9","article-title":"RNA m6A methylation and regulatory proteins in pulmonary arterial hypertension","volume":"47","author":"Wang","year":"2024","journal-title":"Hypertension research: official journal of the Japanese Society of Hypertension"},{"issue":"50","key":"10.1016\/j.pharmthera.2026.109085_bb1380","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/BF01504608","article-title":"\u00dcber den Stoffwechsel der Carcinomzelle","volume":"12","author":"Warburg","year":"1924","journal-title":"Naturwissenschaften"},{"issue":"3191","key":"10.1016\/j.pharmthera.2026.109085_bb1385","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109085_bb1390","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163932","article-title":"Proline and glucose metabolic reprogramming supports vascular endothelial and medial biomass in pulmonary arterial hypertension","volume":"8","author":"Wertheim","year":"2023","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109085_bb1395","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jacc.2023.05.063","article-title":"Right atrial adaptation to precapillary pulmonary hypertension: Pressure-volume, cardiomyocyte, and histological analysis","volume":"82","author":"Wessels","year":"2023","journal-title":"Journal of the American College of Cardiology"},{"issue":"48","key":"10.1016\/j.pharmthera.2026.109085_bb1400","doi-asserted-by":"crossref","first-page":"18782","DOI":"10.1073\/pnas.0810199105","article-title":"Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction","volume":"105","author":"Wise","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb1405","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1186\/s12967-024-05543-7","article-title":"Lactate dehydrogenase A (LDHA)-mediated lactate generation promotes pulmonary vascular remodeling in pulmonary hypertension","volume":"22","author":"Wu","year":"2024","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1410","article-title":"Inactivation of AXL in cardiac fibroblasts alleviates right ventricular remodeling in pulmonary hypertension","author":"Wu","year":"2025","journal-title":"Advanced Science"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109085_bb1415","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ame2.12220","article-title":"Experimental animal models of pulmonary hypertension: Development and challenges","volume":"5","author":"Wu","year":"2022","journal-title":"Animal Models and Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1420","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.117212","article-title":"Dehydrodiisoeugenol inhibits PDGF-BB-induced proliferation and migration of human pulmonary artery smooth muscle cells via the mTOR\/HIF1-\u03b1\/HK2 signaling pathway","volume":"495","author":"Xie","year":"2025","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb1425","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1038\/s41598-022-06848-7","article-title":"Endothelial cell ferroptosis mediates monocrotaline-induced pulmonary hypertension in rats by modulating NLRP3 inflammasome activation","volume":"12","author":"Xie","year":"2022","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1430","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev-physiol-031620-123956","article-title":"Metabolism in pulmonary hypertension","volume":"83","author":"Xu","year":"2021","journal-title":"Annual Review of Physiology"},{"issue":"14","key":"10.1016\/j.pharmthera.2026.109085_bb1435","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1096\/fj.04-2317fje","article-title":"Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension","volume":"18","author":"Xu","year":"2004","journal-title":"FASEB Journal\u202f: Official Publication of the Federation of American Societies for Experimental Biology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109085_bb1440","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1073\/pnas.0605080104","article-title":"Alterations of cellular bioenergetics in pulmonary artery endothelial cells","volume":"104","author":"Xu","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1445","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1721071","article-title":"Macrophage-driven immunopathology in pulmonary arterial hypertension: from mechanisms to targeted therapies","volume":"16","author":"Xu","year":"2025","journal-title":"Frontiers in Immunology"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109085_bb1450","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/s12276-023-01020-1","article-title":"Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential","volume":"55","author":"Xu","year":"2023","journal-title":"Experimental & Molecular Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109085_bb1455","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/CIRCRESAHA.112.266361","article-title":"Enhanced Ca2+-sensing receptor function in idiopathic pulmonary arterial hypertension","volume":"111","author":"Yamamura","year":"2012","journal-title":"Circulation Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109085_bb1460","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1161\/CIRCRESAHA.113.300897","article-title":"Dihydropyridine Ca2+ channel blockers increase cytosolic [Ca2+] by activating Ca2+-sensing receptors in pulmonary arterial smooth muscle cells","volume":"112","author":"Yamamura","year":"2013","journal-title":"Circulation Research"},{"issue":"50","key":"10.1016\/j.pharmthera.2026.109085_bb1465","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba2470","article-title":"DNA methyltransferase 3B deficiency unveils a new pathological mechanism of pulmonary hypertension","volume":"6","author":"Yan","year":"2020","journal-title":"Science Advances"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb1470","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-026-02584-w","article-title":"Regulatory T cells in cancer and inflammation","volume":"11","author":"Yang","year":"2026","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb1475","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1165\/rcmb.2015-0002OC","article-title":"Peroxisome proliferator-activated receptor \u03b3-mediated inhibition on hypoxia-triggered store-operated calcium entry. A caveolin-1-dependent mechanism","volume":"53","author":"Yang","year":"2015","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1480","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.niox.2023.08.004","article-title":"Endothelin-1 acutely increases nitric oxide production via the calcineurin mediated dephosphorylation of Caveolin-1","volume":"140-141","author":"Yegambaram","year":"2023","journal-title":"Nitric Oxide: Biology and Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1485","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103765","article-title":"c-Myc promotes metabolic reprogramming in pulmonary hypertension via the stimulation of glutaminolysis and the reductive tricarboxylic acid cycle","volume":"85","author":"Yegambaram","year":"2025","journal-title":"Redox Biology"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1490","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.freeradbiomed.2023.11.008","article-title":"Mitochondrial hyperfusion induces metabolic remodeling in lung endothelial cells by modifying the activities of electron transport chain complexes I and III","volume":"210","author":"Yegambaram","year":"2024","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1495","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101610","article-title":"Editorial: Metabolic reprogramming and cancer progression","volume":"28","author":"Yin","year":"2023","journal-title":"Translational Oncology"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1500","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102032","article-title":"Metabolic reprogramming and polarization of microglia in Parkinson's disease: Role of inflammasome and iron","volume":"90","author":"Yu","year":"2023","journal-title":"Ageing Research Reviews"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1505","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6526036","article-title":"Inhibition of Bruton's tyrosine kinase alleviates monocrotaline-induced pulmonary arterial hypertension by modulating macrophage polarization","volume":"2022","author":"Yu","year":"2022","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"19","key":"10.1016\/j.pharmthera.2026.109085_bb1510","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1161\/CIRCULATIONAHA.118.035889","article-title":"BOLA (BolA Family Member 3) deficiency controls endothelial metabolism and glycine homeostasis in pulmonary hypertension","volume":"139","author":"Yu","year":"2019","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb1515","first-page":"1474","article-title":"Nonclassical monocytes sense hypoxia, regulate pulmonary vascular remodeling, and promote pulmonary hypertension","volume":"204","author":"Yu","year":"2020","journal-title":"Journal of Immunology (Baltimore, Md.\u202f: 1950)"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb1520","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1165\/rcmb.2019-0401OC","article-title":"Mural cell SDF1 signaling is associated with the pathogenesis of pulmonary arterial hypertension","volume":"62","author":"Yuan","year":"2020","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109085_bb1525","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/j.ajpath.2016.05.016","article-title":"Increased pyruvate dehydrogenase kinase 4 expression in lung pericytes is associated with reduced endothelial-pericyte interactions and small vessel loss in pulmonary arterial hypertension","volume":"186","author":"Yuan","year":"2016","journal-title":"The American Journal of Pathology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb1530","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1124\/mol.51.6.951","article-title":"2-Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: Possible role for stress-activated protein kinase signaling pathway and Fas expression","volume":"51","author":"Yue","year":"1997","journal-title":"Molecular Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb1535","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/ATVBAHA.120.314639","article-title":"Altered macrophage polarization induces experimental pulmonary hypertension and is observed in patients with pulmonary arterial hypertension","volume":"41","author":"Zawia","year":"2021","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1540","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173302","article-title":"Sphingosine-1-phosphate promotes pulmonary artery smooth muscle cells proliferation by stimulating autophagy-mediated E-cadherin\/CDH1 down-regulation","volume":"884","author":"Zhai","year":"2020","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1545","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2023.107157","article-title":"Histone deacetylase inhibitors synergize with sildenafil to suppress purine metabolism and proliferation in pulmonary hypertension","volume":"149","author":"Zhang","year":"2023","journal-title":"Vascular Pharmacology"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109085_bb1550","doi-asserted-by":"crossref","DOI":"10.3390\/cells13110914","article-title":"Fibroblasts in pulmonary hypertension: Roles and molecular mechanisms","volume":"13","author":"Zhang","year":"2024","journal-title":"Cells"},{"issue":"25","key":"10.1016\/j.pharmthera.2026.109085_bb1555","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1161\/CIRCULATIONAHA.117.028069","article-title":"Metabolic and proliferative state of vascular adventitial fibroblasts in pulmonary hypertension is regulated through a MicroRNA-124\/PTBP1 (polypyrimidine tract binding protein 1)\/pyruvate kinase muscle axis","volume":"136","author":"Zhang","year":"2017","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109085_bb1560","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1089\/ars.2011.4168","article-title":"Extracellular calcium-sensing receptor is critical in hypoxic pulmonary vasoconstriction","volume":"17","author":"Zhang","year":"2012","journal-title":"Antioxidants & Redox Signaling"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1565","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111296","article-title":"TG2 participates in pulmonary vascular remodelling by regulating the senescence of pulmonary artery smooth muscle cells","volume":"121","author":"Zhang","year":"2024","journal-title":"Cellular Signalling"},{"issue":"31","key":"10.1016\/j.pharmthera.2026.109085_bb1570","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.2174\/1381612822666160614082712","article-title":"Energetic metabolic roles in pulmonary arterial hypertension and right ventricular remodeling","volume":"22","author":"Zhang","year":"2016","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1575","article-title":"A critical contribution of cardiac myofibroblasts in right ventricular failure and the role of UCP2 SNPs in the predisposition to rv decompensation in pulmonary arterial hypertension","author":"Zhang","year":"2026","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2026.109085_bb1580","article-title":"The role of immune cells and inflammation in pulmonary hypertension: mechanisms and implications","volume":"15","author":"Zhao","year":"2024","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109085_bb1585","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12931-018-0800-5","article-title":"Metabolic reprogramming of the urea cycle pathway in experimental pulmonary arterial hypertension rats induced by monocrotaline","volume":"19","author":"Zheng","year":"2018","journal-title":"Respiratory Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb1590","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3892\/ol.2012.928","article-title":"Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review)","volume":"4","author":"Zheng","year":"2012","journal-title":"Oncology Letters"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109085_bb1595","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1161\/CIRCRESAHA.122.321200","article-title":"Endothelial FIS1 DeSUMOylation protects against hypoxic pulmonary hypertension","volume":"133","author":"Zhou","year":"2023","journal-title":"Circulation Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109085_bb1600","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.yexcr.2017.06.017","article-title":"An upregulation of CD8+CD25+Foxp3+ T cells with suppressive function through interleukin 2 pathway in pulmonary arterial hypertension","volume":"358","author":"Zhu","year":"2017","journal-title":"Experimental Cell Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109085_bb1605","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/HYPERTENSIONAHA.121.18684","article-title":"Platelet-Derived TGF (transforming growth factor)-\u03b21 enhances the aerobic glycolysis of pulmonary arterial smooth muscle cells by PKM2 (pyruvate kinase muscle isoform 2) upregulation","volume":"79","author":"Zhu","year":"2022","journal-title":"Hypertension (Dallas, Tex.: 1979)"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109085_bb1610","first-page":"5118","article-title":"Effect of atorvastatin on pulmonary hypertension rats through regulating notch signaling pathway","volume":"24","author":"Zhu","year":"2020","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109085_bb1615","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/HJH.0000000000001676","article-title":"Sirtuin 1 regulates pulmonary artery smooth muscle cell proliferation: role in pulmonary arterial hypertension","volume":"36","author":"Zurlo","year":"2018","journal-title":"Journal of Hypertension"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826001129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826001129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:48Z","timestamp":1786119288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725826001129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":323,"alternative-id":["S0163725826001129"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109085","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic reprogramming in pulmonary arterial hypertension","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109085"}}